Trabectedin and plitidepsin: drugs from the sea that strike the tumor microenvironment

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Traditional cancer models focus on genetic mutations in oncogenes and tumor suppressor genes.
• Tumors are now understood as complex organ-like structures involving diverse cell types and an inflammatory stroma.
• The tumor microenvironment plays a critical role in cancer cell survival and progression.

Purpose of the Study:

• To review the mechanism of action of marine-derived drugs.
• To highlight how these drugs target both tumor cells and the tumor microenvironment.
• To underscore the tumor microenvironment as a therapeutic target.

Main Methods:

• Review of existing literature on trabectedin and plitidepsin.
• Analysis of their molecular mechanisms of action.
• Examination of their impact on tumor cells and the tumor microenvironment.

Main Results:

• Trabectedin and plitidepsin exhibit antitumor activity through multifaceted mechanisms.
• These drugs demonstrate efficacy not only against cancer cells but also within the tumor microenvironment.
• The complex interplay within the tumor microenvironment is crucial for drug efficacy.

Conclusions:

• Targeting the tumor microenvironment is a promising strategy in cancer therapy.
• Marine-derived compounds like trabectedin and plitidepsin exemplify this novel therapeutic approach.
• Further research into microenvironment-targeted therapies is warranted.